• Home
  • Aktuelles
  • Mayer Brown advised SERB Group on the acquisition of the Veriton Pharma Group
Beteiligte Personen

Paris – Mayer Brown advised SERB Specialty Pharmaceuticals (« SERB »), independent pharmaceutical company in connection with the acquisition of the Veriton Pharma Limited Group, a British pharmaceutical group, from its founder-manager and other members of the management team. 

Mayer Brown advised SERB on the structuring of the acquisition with a team composed of Laurent Borey, Olivier Parawan (partners) and Sarah Rahmoun (associate) in Paris and Matthew Mortimer (partner) and Matthew O'Brien (associate) in London.


Beratungsfelder

Praxis –
Branchen –

Aktuelles

Alle anzeigen